Hyphens Pharma International to raise $13.5m in IPO

It will use the proceeds for overseas expansion.

Hyphens Pharma International launched its initial public offering (IPO) in order to raise $13.5m for its business expansions.

It launched 29.6 million invitation shares, which includes 3 million public offer shares at 26 cents each. Upon the completion of the IPO, the company's market cap will be at $78m.

It has clinched Asian asset manager Nikko Asset Management Asia, Qilin Asset Management, and Maxi-Harvest Group as cornerstone investors.

Hyphens Pharma is a speciality pharmaceutical and consumer healthcare group with a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia, and the Philippines.

It sells speciality pharmaceuticals, a proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore, and medical hypermart and digital supplies.

Hyphens Pharma International chairman, executive director, and CEO Lim See Wah commented, “We will seek to expand and strengthen our product range, as well as maintain growth momentum through scaling our presence in markets that we operate in and expanding into new geographical markets.”

The company intends to continue to expand its range of dermatological and health supplement products in its proprietary brands segment, with plans to launch five products in 2018.

It added that it will capitalise on the first mover advantage it had gained by being the first pharmaceutical wholesaler in Singapore to establish an online platform.

Hyphens Pharma International intends to consolidate its operations in Singapore under a new integrated facility and install an automated packaging facility.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia